(Q37029357)

17 August 2017

1 reference

title

Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy (English)

1 reference

Cecilie Johannessen Landmark

17 August 2017

series ordinal

1

object named as

Cecilie Johannessen Landmark

1 reference

PubMed ID

18072813

17 August 2017

language of work or name

1 reference

1 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

22

1 reference

17 August 2017

1

1 reference

17 August 2017

27-47

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200822010-00003

17 August 2017

0 references

cites work

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822010-00003

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822010-00003

The effect of levetiracetam on essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822010-00003

A double-blind placebo-controlled trial of topiramate treatment for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822010-00003

Migraine throughout the life cycle: treatment through the ages

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822010-00003

Clinical pharmacology of vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822010-00003

Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822010-00003

Shared mechanisms of antidepressant and antiepileptic treatments: drugs and devices

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822010-00003

Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822010-00003

Comorbidity of migraine and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822010-00003

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

12 December 2020

The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.

1 reference

12 December 2020

Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain

1 reference

12 December 2020

An astrocytic basis of epilepsy

1 reference

12 December 2020

An open trial of topiramate in the treatment of generalized social phobia.

1 reference

12 December 2020

The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder

1 reference

12 December 2020

An open-label pilot study of levetiracetam for essential tremor

1 reference

12 December 2020

Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist

1 reference

12 December 2020

The role of GABA in the pathophysiology and treatment of anxiety disorders.

1 reference

12 December 2020

Antiepileptic drugs in mood-disordered patients

1 reference

12 December 2020

Lamotrigine for schizophrenia

1 reference

12 December 2020

Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol

1 reference

12 December 2020

Pharmacotherapy and other treatments for cocaine abuse and dependence

1 reference

12 December 2020

Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01

1 reference

12 December 2020

Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone

1 reference

12 December 2020

What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?

1 reference

12 December 2020

Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study

1 reference

12 December 2020

Potential Mechanisms of Action of Lamotrigine in the Treatment of Bipolar Disorders

1 reference

12 December 2020

Antiepileptic drugs: indications other than epilepsy.

1 reference

12 December 2020

Topiramate add-on in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial

1 reference

12 December 2020

Search for a common mechanism of mood stabilizers.

1 reference

12 December 2020

Effects of topiramate in patients with cerebellar tremor

1 reference

12 December 2020

Epileptogenesis and rational therapeutic strategies

1 reference

12 December 2020

Altered gene expression in mice treated with the mood stabilizer sodium valproate

1 reference

12 December 2020

A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction

1 reference

12 December 2020

Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy

1 reference

12 December 2020

Molecular pharmacology of topiramate: managing seizures and preventing migraine

1 reference

12 December 2020

Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics

1 reference

12 December 2020

A controlled study comparing visual function in patients treated with vigabatrin and tiagabine

1 reference

12 December 2020

Antiepileptic drugs in schizophrenia: a review

1 reference

12 December 2020

Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami.

1 reference

12 December 2020

The role of anticonvulsants in preventive migraine therapy

1 reference

12 December 2020

The acute effect of valproate on cerebral energy metabolism in mice

1 reference

12 December 2020

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

1 reference

12 December 2020

Phenytoin, an anti-bipolar anticonvulsant: a potential anti-glucocorticoid mechanism?

1 reference

12 December 2020

Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders

1 reference

12 December 2020

The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study

1 reference

12 December 2020

Felbamate relieves several abnormal pain sensations in rats with an experimental peripheral neuropathy.

1 reference

12 December 2020

Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.

1 reference

12 December 2020

Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease

1 reference

12 December 2020

The mechanisms of action of gabapentin and pregabalin

1 reference

12 December 2020

Depression and mania in patients with epilepsy

1 reference

12 December 2020

Intravenous fosphenytoin in acute mania

1 reference

12 December 2020

Effects of gabapentin on spontaneous discharges and subthreshold membrane potential oscillation of type A neurons in injured DRG.

1 reference

12 December 2020

Mood disorders and their treatment in patients with epilepsy

1 reference

12 December 2020

Disfluent speech in patients with partial epilepsy: beneficial effect of levetiracetam.

1 reference

12 December 2020

Valproic acid inhibits substance P-induced activation of protein kinase C epsilon and expression of the substance P receptor

1 reference

12 December 2020

Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders.

1 reference

12 December 2020

Inositol augmentation of lithium or valproate for bipolar depression.

1 reference

12 December 2020

Lamotrigine for neuropathic pain

1 reference

12 December 2020

Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies

1 reference

12 December 2020

Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids

1 reference

12 December 2020

Non-epilepsy uses of antiepilepsy drugs.

1 reference

12 December 2020

Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).

1 reference

12 December 2020

Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Essential tremor: differential diagnosis and current therapy

1 reference

12 December 2020

Visual field defects with vigabatrin: epidemiology and therapeutic implications

1 reference

12 December 2020

Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction.

1 reference

12 December 2020

Bronchial asthma as neurogenic paroxysmal inflammatory disease: a randomized trial with carbamazepine

1 reference

12 December 2020

Molecular targets versus models for new antiepileptic drug discovery

1 reference

12 December 2020

New antiepileptic drugs that are second generation to existing antiepileptic drugs

1 reference

12 December 2020

Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors

1 reference

12 December 2020

Diverse mechanisms of antiepileptic drugs in the development pipeline

1 reference

12 December 2020

Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor

1 reference

12 December 2020

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

1 reference

12 December 2020

Action tremor with alternating activity in antagonist muscles

1 reference

12 December 2020

Open-label adjunctive topiramate in the treatment of unstable bipolar disorder

1 reference

12 December 2020

Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.

1 reference

12 December 2020

The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver

1 reference

12 December 2020

Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder.

1 reference

12 December 2020

Pharmacology of valproate

1 reference

12 December 2020

Anticonvulsants in the treatment of bipolar mania

1 reference

12 December 2020

Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia.

1 reference

12 December 2020

Effects of valproic acid on an animal model of tardive dyskinesia.

1 reference

12 December 2020

Shared mechanisms and comorbidities in neurologic and psychiatric disorders

1 reference

12 December 2020

Topiramate in migraine prevention: results of a large controlled trial

1 reference

12 December 2020

Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders

1 reference

12 December 2020

Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery

1 reference

12 December 2020

Gabapentin can improve postural stability and quality of life in primary orthostatic tremor

1 reference

12 December 2020

Wolff Award 1996. The actions of valproate and neurosteroids in a model of trigeminal pain.

1 reference

12 December 2020

Epilepsy and migraine

1 reference

12 December 2020

GABA-based therapeutic approaches: GABAA receptor subtype functions

1 reference

12 December 2020

Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial

1 reference

12 December 2020

Centrally mediated antihyperalgesic and antiallodynic effects of zonisamide following partial nerve injury in the mouse

1 reference

12 December 2020

Valproate: past, present, and future.

1 reference

12 December 2020

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

1 reference

12 December 2020

Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate

1 reference

12 December 2020

Valproate and the symptomatic treatment of schizophrenia spectrum patients

1 reference

12 December 2020

Mechanisms of the antinociceptive action of gabapentin.

1 reference

12 December 2020

An introduction to antiepileptic drugs

1 reference

12 December 2020

Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura

1 reference

12 December 2020

1 reference

12 December 2020

Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study

1 reference

12 December 2020

Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats

1 reference

12 December 2020

Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice.

1 reference

12 December 2020

Nuclear magnetic resonance detection of increased cortical GABA in vigabatrin-treated rats in vivo.

1 reference

12 December 2020

Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics

1 reference

12 December 2020

Nonepileptic uses of antiepileptic drugs in children and adolescents

1 reference

12 December 2020

The history of valproate in clinical neuroscience

1 reference

12 December 2020

Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures

1 reference

12 December 2020

Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments

1 reference

12 December 2020

Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder

1 reference

12 December 2020

Antiepileptic drugs and the regulation of mood and quality of life (QOL): the evidence from epilepsy

1 reference

12 December 2020

The role of GABA in anxiety disorders

1 reference

12 December 2020

Efficacy of topiramate and valproate in chronic migraine.

1 reference

12 December 2020

Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives

1 reference

12 December 2020

Mechanisms of action of antiepileptic drugs.

1 reference

12 December 2020

Phenytoin as an antimanic anticonvulsant: a controlled study

1 reference

12 December 2020

Mechanisms of action of valproate: a commentatory

1 reference

12 December 2020

Convergent effects of lithium and valproate on the expression of proteins associated with large dense core vesicles in NGF-differentiated PC12 cells.

1 reference

12 December 2020

Genetic mouse models of essential tremor: are they essential?

1 reference

12 December 2020

The new generation of GABA enhancers. Potential in the treatment of epilepsy

1 reference

12 December 2020

Depression in epilepsy: a neurobiologic perspective

1 reference

12 December 2020

Valproate disrupts regulation of inositol responsive genes and alters regulation of phospholipid biosynthesis

1 reference

12 December 2020

Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics

1 reference

12 December 2020

Astrocytes get in the act in epilepsy

1 reference

12 December 2020

Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania

1 reference

12 December 2020

Carbamazepine versus Diphenylhydantoin in the Treatment of Myotonia

1 reference

12 December 2020

Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites

1 reference

12 December 2020

Valproic acid in prophylaxis of refractory migraine

1 reference

12 December 2020

Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia

1 reference

12 December 2020

Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study

1 reference

12 December 2020

Algorithm for neuropathic pain treatment: an evidence based proposal.

1 reference

12 December 2020

Glutamate and schizophrenia: beyond the dopamine hypothesis

1 reference

12 December 2020

A common mechanism of action for three mood-stabilizing drugs

1 reference

12 December 2020

Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain

1 reference

12 December 2020

Valproate oral loading in the treatment of acute mania

1 reference

12 December 2020

Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study

1 reference

12 December 2020

Neurochemical underpinnings in bipolar disorder and epilepsy

1 reference

12 December 2020

Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain

1 reference

12 December 2020

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

1 reference

12 December 2020

Valproate decreases inositol biosynthesis

1 reference

12 December 2020

Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders.

1 reference

12 December 2020

Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)

1 reference

12 December 2020

Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

The neurobiology of antiepileptic drugs

1 reference

12 December 2020

Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis.

1 reference

12 December 2020

10.2165/00023210-200822010-00003

Identifiers

DOI

1 reference

PubMed ID

18072813

Dimensions Publication ID

17 August 2017

0 references

1 reference

PubMed ID

18072813